CLDN3 was reported as a positive regulator of cancer stemness in nonsquamous NSCLC and its depletion decreased the formation rates of spheres and tumours and increased cisplatin sensitivity (Ma et al., 2019). This evidence concerns the gene CLDN3 and neoplasm.